Novel peptides inhibiting the maturation of t-lymphocytes and th

Details Novel peptides inhibiting the maturation of t-lymphocytes and th Novel peptides inhibiting the maturation of t-lymphocytes and th

1990-01-09

1992-03-03

Lee, Lester L.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

530330, 530331, C07K 508, C07K 510, A61K 3702

Patent

active

050933205

ABSTRACT:
Peptides are disclosed which inhibit the immune system. The peptides are selected from the group consisting of:

REFERENCES:
patent: 4190646 (1980-02-01), Goldstein et al.
patent: 4215112 (1980-07-01), Goldstein et al.
patent: 4395404 (1983-07-01), Low et al.
patent: 4428938 (1984-01-01), Kisfaludy et al.
patent: 4442031 (1984-04-01), Felix et al.
Drugs Exptl Clin Res XIII(6) 327-337 (1987), Talmadge J. E. et al.,
Drugs of the Future, 11, pp. 784-793 (1986).
U.S. patent application Ser. No. 07/123,124 (allowed) filed 20 Nov. 1977, which is equivalent to Hungarian Patent 4,827,186.

Affiliated with

Also associated with

Rating

Novel peptides inhibiting the maturation of t-lymphocytes and th does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel peptides inhibiting the maturation of t-lymphocytes and th, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel peptides inhibiting the maturation of t-lymphocytes and th will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-272252